Furthermore, the levels of other AD biomarkers, such as vascular endothelial growth factor (VEGF) [61] and transforming growth factor-β1 (TGF-β1) [62], were higher in the CSF of AD patients. Here, VEGFA is linked to Alzheimer disease.